Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC today announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Valeant Pharmaceuticals’ Edecrin®* tablets (Ethacrynic Acid Tablets 25mg). Prior to today, there have been no FDA approved generic versions of Edecrin®* tablets and Edenbridge intends to begin shipping its Ethacrynic Acid Tablets USP 25mg product shortly. Ethacrynic Acid is a potent diuretic indicated for the treatment of edema. For more information please contact the Company directly at info@dexcelpharmausa.com.
Ethacrynic Acid Tablets, USP Approval
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.